Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Anitza Lopez
Clinical Research Coordinator I
Dept of Emergency Medicine
Full Page
Overview
Research
More
Collaboration
(16)
Jarrod Mosier
Mutual work: 10 Proposals﹒7 Grants
Collaboration Details
Karen Lutrick
Mutual work: 3 Grants﹒5 Proposals
Collaboration Details
Farshad Shirazi
Mutual work: 3 Proposals﹒3 Grants
Collaboration Details
Christian Bime
Mutual work: 2 Grants﹒2 Proposals
Collaboration Details
Srikar Adhikari
Mutual work: 1 Supervisor﹒3 Proposals
Collaboration Details
Page 1 of 4
Previous page
Next page
Grants
(8)
A Randomized Controlled Trial to Evaluate the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose at Increased Risk of Liver Injury
Active
·
2024
·
$0 / $274.2K
·
External
pharmacology,
toxicology,
clinical trials,
hepatology,
emergency medicine
Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Varespladib Followed by Oral Varespladib in Addition to Standard of Care in Subje
Active
·
2023
·
$0 / $1.5M
·
External
pharmaceuticals,
clinical trials,
drug efficacy,
safety assessment,
standard of care
A Phase III, Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infec
Active
·
2023
·
$0 / $1.3M
·
External
clinical trials,
immunotherapy,
infectious diseases,
respiratory medicine,
drug safety
PUERTA (Pioneering The Utility Of eNAMPT-Reducing Therapies In Acute Respiratory Distress Syndrome [ARDS]/ Ventilator-induced Lung Injury [VILI]): An Adaptive Phase 2a, Multi-center, Randomized, Doubl
Active
·
2023
·
$0 / $498.4K
·
External
clinical trial,
respiratory distress,
drug efficacy,
safety assessment
Novel ?2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
Active
·
2023
·
$0 / $45.8K
·
External
thrombolysis,
antiplasmin,
intravascular,
clinical trial,
lysis
Page 1 of 2
Previous page
Next page
